Types of Diabetes, Humulin N Treatment, and Dietary Care
This paper provides an overview of the major types of diabetes—type 1, type 2, gestational, and juvenile—explaining how each differs in terms of insulin function and affected populations. It describes the physiological role of insulin in regulating blood glucose and the metabolic consequences when that regulation fails. The paper then examines Humulin N, an intermediate-acting insulin isophane used to treat type 2 and gestational diabetes, and outlines dietary strategies to support glycemic control. Short-term risks such as hypoglycemia and allergic reactions are discussed alongside long-term macrovascular and microvascular complications, concluding that a combination of medication, diet, and exercise is essential to managing type 2 diabetes effectively.
- Introduction to Diabetes Types: Classifies type 1, type 2, and gestational diabetes
- How Insulin Regulates Blood Glucose: Explains insulin's role in glucose metabolism
- Humulin N as a Treatment for Type 2 Diabetes: Describes Humulin N insulin isophane therapy
- Dietary Considerations for Managing Diabetes: Recommends low-sugar, organic diet strategies
- Short-Term Risks and Side Effects: Covers hypoglycemia and Humulin N side effects
- Long-Term Complications of Type 2 Diabetes: Discusses macrovascular and microvascular damage
- Conclusion: Summarizes diabetes types and treatment approach
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper clearly distinguishes between the three major diabetes types before narrowing its focus to treatment, giving readers essential context before introducing pharmacological content.
- It integrates both pharmacological (Humulin N) and lifestyle (diet, exercise) management strategies, reflecting a holistic approach to patient care.
- Short-term and long-term complication sections are kept separate, which helps readers understand the temporal progression of disease risk.
Key academic technique demonstrated
The paper demonstrates effective use of classification as an organizational strategy. By first categorizing diabetes types and then moving systematically through physiology, pharmacology, diet, and complications, the writer creates a logical scaffold that guides the reader from foundational concepts to applied clinical considerations. Each section builds on the one before it, reinforcing coherence across the argument.
Structure breakdown
The paper follows a six-part expository structure: (1) classification of diabetes types, (2) physiological mechanism of insulin, (3) pharmacological treatment with Humulin N, (4) dietary management, (5) short-term side effects and risks, and (6) long-term vascular complications, followed by a brief summary conclusion. This structure mirrors the clinical reasoning process—diagnosis, mechanism, treatment, lifestyle, and risk monitoring—making it well-suited for a health sciences audience.
Introduction to Diabetes Types
There are various types of diabetes, including type 1, type 2, gestational, and juvenile diabetes. Type 1 diabetes occurs when the body fails to produce adequate amounts of insulin. It most often affects children and young adults, which is why it is also referred to as juvenile diabetes. Type 2 diabetes occurs when cells fail to respond to insulin properly. This subtle distinction makes a great deal of difference in terms of treating the two types of diabetes (Arcangelo & Peterson, 2006). It is also worth noting that type 2 diabetes tends to develop later in life, typically around middle age, though it can occur earlier. Moreover, 90% of all diabetes cases are type 2 diabetes.
Gestational diabetes occurs in pregnant women who have never had diabetes but who develop high blood sugar levels during pregnancy. Nearly one in ten women is at risk of developing gestational diabetes. Gestational diabetes can also return as type 2 diabetes in affected women later in life (Laureate Education, 2012).
References
Arcangelo, V. P., & Peterson, A. M. (Eds.). (2006). Pharmacotherapeutics for advanced practice: A practical approach (Vol. 536). Lippincott Williams & Wilkins.
Drugs.com. (2012). Retrieved from
Laureate Education, Inc. (Executive Producer). (2012). The endocrine system and diabetes. Baltimore, MD: Author.
Hruby, A., & Hu, F. B. (2015). The epidemiology of obesity: A big picture. Pharmacoeconomics, 33(7), 673–689.
Torpy, J. M., Burke, A. E., & Glass, R. M. (2009). Coronary heart disease risk factors. JAMA, 302(21), 2388–2388.
Create your account
Always verify citation format against your institution’s current style guide requirements.